COVID booster vaccinations — both monovalent and bivalent — offer benefits in reducing the risk for severe outcomes of COVID among patients with autoimmune diseases, a US real-world study shows.

For millions of people living with long COVID, symptoms like shortness of breath, mental fog, and deep fatigue continue long after infection, with no clear explanation. Now, a group of leading ...

About Vaxart, Inc. is a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standa ...

During the delta and omicron variant time periods, vaccination against severe acute respiratory syndrome coronavirus-2 ...

The authors of a new Australian study say they have identified a set of 32 genetic variants that increase the likelihood of ...

This study merges causal genetics and network theory, revealing 32 genes linked to long COVID, offering insights for ...

Virtual primary care visits were associated with a 49% higher risk for emergency department (ED) visits in children aged 3 ...

A large study of rats shows that genes shape the gut microbiome in two ways: directly, by influencing an individual’s own ...

Infectious disease doctors explain how they protect themselves against norovirus, a highly infectious virus that wreaks havoc ...

Cocrystal Pharma ( ($COCP) ) has shared an announcement. On December 18, 2025, Cocrystal Pharma announced that the Institutional Review Board at ...